132 related articles for article (PubMed ID: 27917904)
1. Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer.
Cao Y; Zhang H; Liu H; Lin C; Li R; Wu S; He H; Li H; Xu J
Sci Rep; 2016 Dec; 6():38364. PubMed ID: 27917904
[TBL] [Abstract][Full Text] [Related]
2. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients.
Cao Y; Liu H; Zhang H; Lin C; Li R; Wu S; Li H; He H; Zhang W; Xu J
Oncotarget; 2017 Mar; 8(12):20328-20339. PubMed ID: 27780937
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China.
Deng J; Zhang R; Pan Y; Wang B; Wu L; Jiao X; Bao T; Hao X; Liang H
Surgery; 2014 Jul; 156(1):64-74. PubMed ID: 24929759
[TBL] [Abstract][Full Text] [Related]
4. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
6. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
[TBL] [Abstract][Full Text] [Related]
9. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
[TBL] [Abstract][Full Text] [Related]
12. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
13. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
15. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
16. Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer.
Cao Y; Liu H; Li H; Lin C; Li R; Wu S; Zhang H; He H; Zhang W; Xu J
JAMA Surg; 2017 Nov; 152(11):e173120. PubMed ID: 28903131
[TBL] [Abstract][Full Text] [Related]
17. Development and external validation of a nomogram for predicting the conditional probability of survival after D2 lymphadenectomy for gastric cancer: A multicentre study.
Chen QY; Zhong Q; Wang W; Desiderio J; Liu ZY; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Zhou ZW; Parisi A; Huang CM
Eur J Surg Oncol; 2019 Oct; 45(10):1934-1942. PubMed ID: 31027946
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
Wu XJ; Miao RL; Li ZY; Bu ZD; Zhang LH; Wu AW; Zong XL; Li SX; Shan F; Ji X; Ren H; Ji JF
Eur J Surg Oncol; 2015 Jul; 41(7):927-33. PubMed ID: 25913059
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.
Galizia G; Lieto E; Auricchio A; Cardella F; Mabilia A; Diana A; Castellano P; De Vita F; Orditura M
PLoS One; 2017; 12(4):e0173619. PubMed ID: 28380037
[TBL] [Abstract][Full Text] [Related]
20. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
